Trials / Completed
CompletedNCT01371461
Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 390 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Overall improvement, severities and changes of specific clinical symptoms were surveyed in outpatients with depression or in a depressed state to evaluate the efficacy and safety of PAXIL tablets in patients in whom the PAXIL dose was increased and those treated with a constant dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2004-07-01
- Completion
- 2004-10-01
- First posted
- 2011-06-10
- Last updated
- 2017-06-08
Source: ClinicalTrials.gov record NCT01371461. Inclusion in this directory is not an endorsement.